OIM
SGMO

Oracle Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Oracle Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$435K Buy
1,035,742
+31,018
+3% +$16.4K 0.26% 18
2025
Q3 		$677K Buy
+1,004,724
New +$542K 0.42% 17

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Oracle Investment Management's SGMO Position: Q4 2025 in Review

Oracle Investment Management increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 3.1% in Q4 2025, buying an estimated $16.4K and bringing the position to 1,035,742 shares worth $435K. The position accounts for 0.26% of the portfolio, ranked #18.

Oracle Investment Management first reported a position in SGMO in Q3 2025 and has held it in 2 quarters since. The position peaked at $677K in Q3 2025. 105 funds tracked by Wall St. Rank hold SGMO as of Q4 2025.

  • Oracle Investment Management held 1,035,742 shares of SANGAMO THERAPEUTICS INC worth $435K as of Q4 2025.
  • Oracle Investment Management bought 31,018 SANGAMO THERAPEUTICS INC shares in Q4 2025, an estimated $16.4K.
  • SANGAMO THERAPEUTICS INC made up 0.26% of Oracle Investment Management's portfolio in Q4 2025, its #18 holding.
  • Oracle Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2025 and has held it in 2 quarters since.
  • Oracle Investment Management's SANGAMO THERAPEUTICS INC position peaked at $677K in Q3 2025.
  • 105 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2025.

Based on Oracle Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.